Repeated administration of dexamethasone increases phosphoinositide-specific phospholipase C activity and mRNA and protein expression of the phospholipase C beta(1) isozyme in rat brain
Y. Dwivedi et Gn. Pandey, Repeated administration of dexamethasone increases phosphoinositide-specific phospholipase C activity and mRNA and protein expression of the phospholipase C beta(1) isozyme in rat brain, J NEUROCHEM, 73(2), 1999, pp. 780-790
Altered hypothalamic-pituitary-adrenal (HPA) function has been shown to be
associated with changes in mood and behavior. The enzyme phosphoinositide-s
pecific phospholipase C (PI-PLC), an important component of the PI signal t
ransduction system, plays a major role in mediating various physiological f
unctions. In the present study, we investigated the effects of a single dos
e and of repeated administration (0.5 or 1.0 mg/kg for 10 days) of dexameth
asone (DEX), a synthetic glucocorticoid, on PI-PLC activity and on expressi
on of PLC isozymes (beta(1), delta(1), and gamma(1)) in rat brain. Repeated
administration of DEX (1.0 mg/kg) caused a significant increase in PI-PLC
activity and in protein expression of the PLC beta(1) isozyme in both membr
ane and cytosol fractions of cortex and hippocampus; however, the repeated
administration of a smaller dose of DEX (0.5 mg/kg) caused these changes on
ly in hippocampus but not in cortex. The increase in PLC beta(1) protein wa
s associated with an increase in its mRNA level, as measured by competitive
RT-PCR. A single administration of DEX (0.5 or 1.0 mg/kg) to rats had no s
ignificant effects on PI-PLC activity or on the protein expression of PLC i
sozymes. These results suggest that DEX up-regulates PI-PLC in rat brain, w
hich presumably is due to a selective increase in expression of the PLC bet
a(1) isozyme, and that these changes in PI-PLC may be related to HPA axis-m
ediated changes in mood and behavior.